Back to 
Tudor Investment Corp.
Tudor Investment Corp.
LGND
Showing 0 of 15 quarters
Position history for Tudor Investment Corp.'s holdings in Ligand Pharmaceuticals Incorporated
No. Tudor Investment exited its LGND (Ligand Pharmaceuticals) position in Q2 2023. Its Q1 2023 13F listed 5,622 shares worth $414,000. Tudor Investment already held LGND in its Q4 2018 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.